Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0000875320-24-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-14 | 2024-02-12+ | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $419.42 | -3,393 | 28.3K | -11% | -$1.42M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | S | D | 647 | $420.39 | 27,644 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $420.39 (range $420.21 to $420.94). |
| 2 | Common | Common Stock | 2024-02-13 | S | D | 737 | $419.13 | 26,907 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $419.13 (range $419.00 to $419.37). (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-02-12 | S | D | 2,009 | $419.22 | 28,291 | D | — | — | (F2) Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $419.22 (range $419.00 to $419.71). |